Status:
UNKNOWN
Unplanned ICU Readmission for Pediatric Liver Transplantation
Lead Sponsor:
RenJi Hospital
Conditions:
Liver Transplantation
Eligibility:
All Genders
1-18 years
Brief Summary
To explore the risk factors of unplanned return to Intensive Care Unit (ICU) in pediatric liver transplant recipients, and to provide data support for the transfer of pediatric liver transplant recipi...
Detailed Description
In recent years, with the progress of medical level, pediatric liver transplantation has been used in a variety of pediatric end-stage liver diseases, such as intrahepatic cholestasis, metabolic disea...
Eligibility Criteria
Inclusion
- (1) Liver transplantation was performed from January, 2018 to December, 31, 2021.21;
- (2) Age \< 18 years;
- (3) The patient was admitted to ICU for the first time due to postoperative monitoring after liver transplantation;
- (4) Survival on first transfer from ICU.
Exclusion
- (1) Death during ICU stay after liver transplantation;
- (2) non-first-time recipients of liver transplantation;
- (3) Patients with complex conditions who were transferred to ICU for life support (such as mechanical ventilation, CRRT, etc.) before operation;
- (4) Patients admitted to ICU by appointment for surgical reasons.
- (5) Patients forcibly transferred from ICU.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 28 2024
Estimated Enrollment :
1575 Patients enrolled
Trial Details
Trial ID
NCT06162260
Start Date
December 1 2023
End Date
December 28 2024
Last Update
December 8 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.